GCP
PRAH
GSA Capital Partners’s PRA Health Sciences, Inc. PRAH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,916
| Closed | -$317K | – | 1925 |
|
|
2021
Q2 | $317K | Buy |
+1,916
| New | +$317K | 0.04% | 912 |
|
|
2020
Q1 | – | Sell |
-28,079
| Closed | -$3.12M | – | 1738 |
|
|
2019
Q4 | $3.12M | Buy |
28,079
+3,847
| +16% | +$428K | 0.36% | 10 |
|
|
2019
Q3 | $2.41M | Buy |
24,232
+5,202
| +27% | +$516K | 0.33% | 9 |
|
|
2019
Q2 | $1.89M | Sell |
19,030
-202
| -1% | -$20K | 0.21% | 49 |
|
|
2019
Q1 | $2.12M | Buy |
19,232
+1,912
| +11% | +$211K | 0.21% | 56 |
|
|
2018
Q4 | $1.59M | Sell |
17,320
-3,258
| -16% | -$300K | 0.18% | 87 |
|
|
2018
Q3 | $2.27M | Sell |
20,578
-419
| -2% | -$46.2K | 0.13% | 189 |
|
|
2018
Q2 | $1.96M | Sell |
20,997
-16,771
| -44% | -$1.57M | 0.1% | 291 |
|
|
2018
Q1 | $3.13M | Sell |
37,768
-19,682
| -34% | -$1.63M | 0.17% | 101 |
|
|
2017
Q4 | $5.23M | Buy |
57,450
+34,510
| +150% | +$3.14M | 0.32% | 13 |
|
|
2017
Q3 | $1.75M | Sell |
22,940
-24,678
| -52% | -$1.88M | 0.12% | 198 |
|
|
2017
Q2 | $3.57M | Buy |
47,618
+21,836
| +85% | +$1.64M | 0.23% | 37 |
|
|
2017
Q1 | $1.68M | Sell |
25,782
-18,391
| -42% | -$1.2M | 0.09% | 334 |
|
|
2016
Q4 | $2.44M | Sell |
44,173
-12,162
| -22% | -$670K | 0.15% | 148 |
|
|
2016
Q3 | $3.18M | Buy |
56,335
+1,811
| +3% | +$102K | 0.17% | 87 |
|
|
2016
Q2 | $2.28M | Sell |
54,524
-2,933
| -5% | -$122K | 0.13% | 185 |
|
|
2016
Q1 | $2.46M | Sell |
57,457
-7,017
| -11% | -$300K | 0.16% | 117 |
|
|
2015
Q4 | $2.92M | Buy |
64,474
+2,438
| +4% | +$110K | 0.14% | 132 |
|
|
2015
Q3 | $2.41M | Buy |
62,036
+5,164
| +9% | +$201K | 0.12% | 189 |
|
|
2015
Q2 | $2.07M | Buy |
56,872
+4,405
| +8% | +$160K | 0.08% | 355 |
|
|
2015
Q1 | $1.51M | Buy |
+52,467
| New | +$1.51M | 0.06% | 537 |
|